Both in Biotechnology
Quince Therapeutics vs Cel-Sci
Over the past year QNCX returned −90.3% and CVM returned −79.7%; their daily moves had a correlation of 0.03.
QNCX −90.3% CVM −79.7%Growth of $1, one year, split-adjusted
| Metric | QNCX | CVM |
|---|---|---|
| Price | $31.17 | $1.79 |
| Market cap | $31.7M | $31.5M |
| Today | +7.48% | +5.29% |
| 1 month | −7.6% | +14.7% |
| 6 months | +53.9% | −41.7% |
| Year to date | −95.3% | −66.0% |
| 1 year | −90.3% | −80.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $116.0M | $255.6K |
| Dividend yield | — | — |
| Volatility (60d) | 71.9% | 81.5% |
| Short % of float | 0.3% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).